{"title":"Micropore visualization and lifetime following microneedle application to skin of differing pigments.","authors":"Valeria Cota, Nicole K Brogden","doi":"10.1007/s13346-025-01817-9","DOIUrl":null,"url":null,"abstract":"<p><p>Solid microneedles allow dermal delivery of drugs that cannot otherwise absorb through skin, via creation of epidermal micropores. The time that the micropores remain open (micropore lifetime) directly impacts drug delivery windows, and darker skin types have extended micropore lifetimes. Here we visualized dermal micropores and measured micropore lifetime in subjects with differing skin pigmentation (ClinicalTrials.gov identifier NCT04867733, registered 29th April 2021). Forty-nine subjects completed the study, self-identifying as Asian, Black, Caucasian, Latinx, and Bi-/multi-racial. Using a colorimeter, skin color was objectively measured and subjects were grouped according to dark (n = 13), medium (n = 19), or light (n = 17) skin. Stainless steel microneedles, 800 μm length, were applied to the arm. Impedance measurements confirmed a breach of skin barrier, suggesting adequate micropore formation. Micropore depth immediately post-microneedle application ranged from 70.3 to 106.6 μm across all subjects (n = 98 total measurements), but was not different between skin color groups, P > 0.05. OCT images were used to calculate micropore closure over 48 h. At 24 h there was no difference in % change in micropore depth between groups. By 48 h there was an 18.1% difference in micropore closure between the lightest and darkest skinned groups, P < 0.05. These data were in agreement with impedance-predicted micropore lifetimes. The longer micropore lifetime in darker skin was independent of micropore depth, and future mechanistic studies of physiological processes underlying these observations would contribute to an understudied area in skin of color research. Proof of concept pharmacokinetics studies would also be useful to investigate the full impact of these differences.</p>","PeriodicalId":11357,"journal":{"name":"Drug Delivery and Translational Research","volume":" ","pages":"3528-3541"},"PeriodicalIF":5.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12353774/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery and Translational Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13346-025-01817-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Solid microneedles allow dermal delivery of drugs that cannot otherwise absorb through skin, via creation of epidermal micropores. The time that the micropores remain open (micropore lifetime) directly impacts drug delivery windows, and darker skin types have extended micropore lifetimes. Here we visualized dermal micropores and measured micropore lifetime in subjects with differing skin pigmentation (ClinicalTrials.gov identifier NCT04867733, registered 29th April 2021). Forty-nine subjects completed the study, self-identifying as Asian, Black, Caucasian, Latinx, and Bi-/multi-racial. Using a colorimeter, skin color was objectively measured and subjects were grouped according to dark (n = 13), medium (n = 19), or light (n = 17) skin. Stainless steel microneedles, 800 μm length, were applied to the arm. Impedance measurements confirmed a breach of skin barrier, suggesting adequate micropore formation. Micropore depth immediately post-microneedle application ranged from 70.3 to 106.6 μm across all subjects (n = 98 total measurements), but was not different between skin color groups, P > 0.05. OCT images were used to calculate micropore closure over 48 h. At 24 h there was no difference in % change in micropore depth between groups. By 48 h there was an 18.1% difference in micropore closure between the lightest and darkest skinned groups, P < 0.05. These data were in agreement with impedance-predicted micropore lifetimes. The longer micropore lifetime in darker skin was independent of micropore depth, and future mechanistic studies of physiological processes underlying these observations would contribute to an understudied area in skin of color research. Proof of concept pharmacokinetics studies would also be useful to investigate the full impact of these differences.
期刊介绍:
The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.
Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.
Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;
Preclinical and clinical data related to drug delivery systems;
Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes
Short-term and long-term biocompatibility of drug delivery systems, host response;
Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;
Image-guided drug therapy,
Nanomedicine;
Devices for drug delivery and drug/device combination products.
In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.